WO2024077078A3 - Sterylglucosidase inhibiting compositions and method of using - Google Patents
Sterylglucosidase inhibiting compositions and method of using Download PDFInfo
- Publication number
- WO2024077078A3 WO2024077078A3 PCT/US2023/075977 US2023075977W WO2024077078A3 WO 2024077078 A3 WO2024077078 A3 WO 2024077078A3 US 2023075977 W US2023075977 W US 2023075977W WO 2024077078 A3 WO2024077078 A3 WO 2024077078A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sterylglucosidase
- inhibiting compositions
- fungus
- inhibiting
- compositions
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 241000233866 Fungi Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a method of inhibiting growth of a fungus in a subject, comprising reducing the activity of sterylglucosidase I (SigIl) and/or sterylglucosidase A (SglA) in the fungus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263378403P | 2022-10-05 | 2022-10-05 | |
US63/378,403 | 2022-10-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2024077078A2 WO2024077078A2 (en) | 2024-04-11 |
WO2024077078A3 true WO2024077078A3 (en) | 2024-05-30 |
Family
ID=90609049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/075977 WO2024077078A2 (en) | 2022-10-05 | 2023-10-04 | Sterylglucosidase inhibiting compositions and method of using |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024077078A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143935A (en) * | 1990-10-16 | 1992-09-01 | Teikoku Chemical Industry Co., Ltd. | Benzamide derivatives |
US9067955B2 (en) * | 2001-04-24 | 2015-06-30 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds |
US20180085442A1 (en) * | 2016-08-10 | 2018-03-29 | The Research Foundation For The State University Of New York | Vaccine compositions against pathogenic fungi and methods for use thereof |
US10287521B2 (en) * | 2012-03-16 | 2019-05-14 | Keclon S.A. | Enzymatic removal of steryl glycosides |
-
2023
- 2023-10-04 WO PCT/US2023/075977 patent/WO2024077078A2/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143935A (en) * | 1990-10-16 | 1992-09-01 | Teikoku Chemical Industry Co., Ltd. | Benzamide derivatives |
US9067955B2 (en) * | 2001-04-24 | 2015-06-30 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds |
US10287521B2 (en) * | 2012-03-16 | 2019-05-14 | Keclon S.A. | Enzymatic removal of steryl glycosides |
US20180085442A1 (en) * | 2016-08-10 | 2018-03-29 | The Research Foundation For The State University Of New York | Vaccine compositions against pathogenic fungi and methods for use thereof |
Non-Patent Citations (1)
Title |
---|
PEREIRA DE SA, TAOUIL ADAM, KIM JINWOO, CLEMENT TIMOTHY, HOFFMANN REECE M., BURKE JOHN E., RIZZO ROBERT C., OJIMA IWAO, DEL POETA : "Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents", NATURE COMMUNICATIONS, NATURE PUBLISHING GROUP, UK, vol. 12, no. 1, UK, XP093177512, ISSN: 2041-1723, DOI: 10.1038/s41467-021-26163-5 * |
Also Published As
Publication number | Publication date |
---|---|
WO2024077078A2 (en) | 2024-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2162818T3 (en) | ANTI-PROLIFERATIVE QUINAZOLINS. | |
WO2019177375A8 (en) | 2, 4, 5-substituted pyrimidine derivatives, method for preparing same, and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | |
WO2021178933A3 (en) | Class ii, type v crispr systems | |
MXPA05005243A (en) | Edible film for relief of cough or symptoms associated with pharyngitis. | |
WO2003091276A3 (en) | Compositions and methods of use of peptides in combination with biocides and/or germicides | |
WO2005040320A3 (en) | Stable compositions of spores, bacteria and/or fungi | |
NZ619325A (en) | Combinations comprising a fungicidal strain and an active compound | |
AU2003298880A1 (en) | Coating for implantable devices and a method of forming the same | |
WO2005019241A3 (en) | Cationic antimicrobial peptides and compositions thereof | |
WO2000034265A3 (en) | Quinoline-indole antimicrobial agents | |
EP2311466A3 (en) | Antimicrobial compounds and methods for their use | |
WO2020247701A3 (en) | Inhibitors of sarm1 | |
WO2021195470A3 (en) | Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2 | |
WO2024077078A3 (en) | Sterylglucosidase inhibiting compositions and method of using | |
WO2022020353A3 (en) | Methods and compositions for treatment and prevention of coronavirus infection | |
AU4985996A (en) | Control of post-harvest fungal disease using saprophytic yeast | |
WO2005005382A3 (en) | Compounds, compositions and methods | |
AU2267899A (en) | Fungi of the genus piriformospora | |
WO2004002430A3 (en) | Combinations for the treatment of fungal infections | |
CA2213575A1 (en) | Alkali metal formononetin and method of mycorrhizal stimulation | |
Lee et al. | 5-Methylmellein and nectriapyrone, two new monoamine oxidase inhibitors | |
WO2023023156A8 (en) | Acid ceramidase inhibitors and uses thereof | |
WO2003020922A3 (en) | Enzymes involved in cell wall biosynthesis in filamentous fungi | |
WO2002078720A3 (en) | Antibiotics from bacteria isolated from amphibian skin | |
WO2024050527A3 (en) | Intranasal dihydropyridine compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23875757 Country of ref document: EP Kind code of ref document: A2 |